Moreover, 6q16 deletion has also been frequently found in other human cancers, such as breast, lung, colon, ovarian cancers and malignant melanoma46, where loss of FBXL4 may be a driver for cancer progression. This evidence concerns the gene FBXL4 and ovarian cancer.